{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T21:00:08Z","timestamp":1787864408737,"version":"build-2784847793"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T00:00:00Z","timestamp":1512691200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100011111","name":"UCB UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011111","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Adv Ther"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s12325-017-0645-1","type":"journal-article","created":{"date-parts":[[2017,12,8]],"date-time":"2017-12-08T11:22:01Z","timestamp":1512732121000},"page":"100-115","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Using Patient Feedback to Optimize the Design of a Certolizumab Pegol Electromechanical Self-Injection Device: Insights from Human Factors Studies"],"prefix":"10.1007","volume":"35","author":[{"given":"Barbara","family":"Doma\u0144ska","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Stumpp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Poon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkan","family":"Oray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Mountian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clovis","family":"Pichon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,12,8]]},"reference":[{"key":"645_CR1","unstructured":"European Medicines Agency. Annex 1: summary of product characteristics (CIMZIA). 2017. http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Product_Information\/human\/001037\/WC500069763.pdf . Accessed March 2017."},{"issue":"6","key":"645_CR2","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1177\/193229681100500633","volume":"5","author":"BJ Anderson","year":"2011","unstructured":"Anderson BJ, Redondo MJ. What can we learn from patient-reported outcomes of insulin pen devices? J Diabetes Sci Technol. 2011;5(6):1563\u201371.","journal-title":"J Diabetes Sci Technol"},{"issue":"Suppl 2","key":"645_CR3","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1186\/ar996","volume":"6","author":"S Schwartzman","year":"2004","unstructured":"Schwartzman S, Morgan GJ. Does route of administration affect the outcome of TNF antagonist therapy? Arthritis Res Ther. 2004;6(Suppl 2):S19\u201323.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"645_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.2217\/ijr.15.39","volume":"10","author":"MF Marengo","year":"2015","unstructured":"Marengo MF, Suarez-Almazor ME. Improving treatment adherence in patients with rheumatoid arthritis: what are the options? Int J Clin Rheumatol. 2015;10(5):345\u201356.","journal-title":"Int J Clin Rheumatol"},{"issue":"1","key":"645_CR5","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/1477-7525-9-2","volume":"9","author":"D Keininger","year":"2011","unstructured":"Keininger D, Coteur G. Assessment of self-injection experience in patients with rheumatoid arthritis: psychometric validation of the Self-Injection Assessment Questionnaire (SIAQ). Health Qual Life Outcomes. 2011;9(1):2.","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"645_CR6","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.apergo.2011.05.014","volume":"43","author":"A Sheikhzadeh","year":"2012","unstructured":"Sheikhzadeh A, Yoon J, Formosa D, Domanska B, Morgan D, Schiff M. The effect of a new syringe design on the ability of rheumatoid arthritis patients to inject a biological medication. Appl Ergon. 2012;43(2):368\u201375.","journal-title":"Appl Ergon"},{"issue":"10","key":"645_CR7","doi-asserted-by":"publisher","first-page":"2043","DOI":"10.1185\/03007995.2011.616190","volume":"27","author":"T Bailey","year":"2011","unstructured":"Bailey T, Thurman J, Niemeyer M, Schmeisl G. Usability and preference evaluation of a prefilled insulin pen with a novel injection mechanism by people with diabetes and healthcare professionals. Curr Med Res Opin. 2011;27(10):2043\u201352.","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"645_CR8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0749-0712(21)00697-1","volume":"8","author":"B Toledano","year":"1992","unstructured":"Toledano B, Terrono A, Millender L. Reconstruction of the rheumatoid thumb. Hand Clin. 1992;8(1):121\u20139.","journal-title":"Hand Clin"},{"issue":"1","key":"645_CR9","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1080\/17425247.2016.1256283","volume":"14","author":"B Domanska","year":"2017","unstructured":"Domanska B, VanLunen B, Peterson L, Mountian I, Schiff M. Comparative usability study for a certolizumab pegol autoinjection device in patients with rheumatoid arthritis. Expert Opin Drug Deliv. 2017;14(1):15\u201322.","journal-title":"Expert Opin Drug Deliv"},{"key":"645_CR10","unstructured":"US Food and Drug Administration. Human factors studies and related clinical study considerations in combination product design and development. Draft guidance for industry and FDA staff. 2016. https:\/\/www.fda.gov\/downloads\/RegulatoryInformation\/Guidances\/UCM484345.pdf . Accessed March 2017."},{"issue":"5","key":"645_CR11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1586\/17434440.2014.940312","volume":"11","author":"S Borsci","year":"2014","unstructured":"Borsci S, Macredie RD, Martin JL, Young T. How many testers are needed to assure the usability of medical devices? Expert Rev Med Devices. 2014;11(5):513\u201325.","journal-title":"Expert Rev Med Devices"},{"key":"645_CR12","unstructured":"US Food and Drug Administration. Applying human factors and usability engineering to medical devices. Guidance for industry and food and drug and administration staff. 2016. https:\/\/www.fda.gov\/downloads\/MedicalDevices\/\u2026\/UCM259760.pdf . Accessed March 2017."},{"key":"645_CR13","unstructured":"Association for the Advancement of Medical Instrumentation. ANSI\/AAMI\/IEC 62366-1:2015. Medical devices\u2014part 1: application of usability engineering to medical devices. 2015. http:\/\/my.aami.org\/aamiresources\/previewfiles\/6236601_1503_preview.pdf . Accessed May 2017."},{"key":"645_CR14","unstructured":"Medicines & Healthcare products Regulatory Agency. Human factors and usability engineering \u2013 guidance for medical devices including drug-device combination products. 2016. https:\/\/www.gov.uk\/government\/uploads\/system\/uploads\/attachment_data\/file\/528495\/MHRA_Human_factors_draft_guidance_June_2016.pdf . Accessed August 2017."},{"key":"645_CR15","unstructured":"European Commission. Medical Devices. 2017. https:\/\/ec.europa.eu\/growth\/single-market\/european-standards\/harmonised-standards\/medical-devices_en . Accessed August 2017"},{"issue":"1","key":"645_CR16","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1080\/00325481.2017.1251291","volume":"129","author":"DH Collier","year":"2017","unstructured":"Collier DH, Bitman B, Coles A, Liu L, Kumar S, Judd C. A novel electromechanical autoinjector, AutoTouch, for self-injection of etanercept: real-world use and benefits. Postgrad Med. 2017;129(1):118\u201325.","journal-title":"Postgrad Med"},{"key":"645_CR17","first-page":"1061","volume":"8","author":"W Demary","year":"2014","unstructured":"Demary W, Schwenke H, Rockwitz K, Kastner P, Liebhaber A, Schoo U, et al. Subcutaneously administered methotrexate for rheumatoid arthritis, by prefilled syringes versus prefilled pens: patient preference and comparison of the self-injection experience. Patient Prefer Adher. 2014;8:1061\u201371.","journal-title":"Patient Prefer Adher"},{"issue":"11","key":"645_CR18","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s40267-017-0446-2","volume":"33","author":"K Lyseng-Williamson","year":"2017","unstructured":"Lyseng-Williamson K. Certolizumab pegol administration devices: a profile of their use and usability. Drugs Ther Perspect. 2017;33(11):515\u201322.","journal-title":"Drugs Ther Perspect"},{"key":"645_CR19","doi-asserted-by":"publisher","unstructured":"Schiff M, Saunderson S, Mountian I, Hartley P. Chronic disease and self-injection: ethnographic investigations into the patient experience during treatment. Rheumatol Ther. 2017. https:\/\/doi.org\/10.1007\/s40744-017-0080-4","DOI":"10.1007\/s40744-017-0080-4"},{"issue":"12","key":"645_CR20","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1177\/154193121005401226","volume":"54","author":"S Guerlain","year":"2010","unstructured":"Guerlain S, Edwards ET, Edwards ES. Design of a new epinephrine auto-injector to minimize use errors. Proc Hum Factors Ergon Soc Ann Meet. 2010;54(12):929\u201331.","journal-title":"Proc Hum Factors Ergon Soc Ann Meet"},{"key":"645_CR21","doi-asserted-by":"publisher","unstructured":"Calip GS, Adimadhyam S, Xing S, Rincon JC, Lee WJ, Anguiano RH. Medication adherence and persistence over time with self-administered TNF-alpha inhibitors among young adult, middle-aged, and older patients with rheumatologic conditions. Semin Arthritis Rheum. 2017. https:\/\/doi.org\/10.1016\/j.semarthrit.2017.03.010 .","DOI":"10.1016\/j.semarthrit.2017.03.010"},{"issue":"2","key":"645_CR22","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1517\/17425247.2013.746311","volume":"10","author":"A Lugaresi","year":"2013","unstructured":"Lugaresi A. RebiSmart (version 1.5) device for multiple sclerosis treatment delivery and adherence. Expert Opin Drug Deliv. 2013;10(2):273\u201383.","journal-title":"Expert Opin Drug Deliv"},{"issue":"12","key":"645_CR23","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1517\/17425247.2015.1078789","volume":"12","author":"M Moccia","year":"2015","unstructured":"Moccia M, Palladino R, Russo C, Massarelli M, Nardone A, Triassi M, et al. How many injections did you miss last month? A simple question to predict interferon \u03b2-1a adherence in multiple sclerosis. Expert Opin Drug Deliv. 2015;12(12):1829\u201335.","journal-title":"Expert Opin Drug Deliv"},{"key":"645_CR24","doi-asserted-by":"publisher","first-page":"415","DOI":"10.2147\/PPA.S127508","volume":"11","author":"MD Edo Solsona","year":"2017","unstructured":"Edo Solsona MD, Monte Boquet E, Casanova Estruch B, Poveda Andres JL. Impact of adherence on subcutaneous interferon beta-1a effectiveness administered by Rebismart\u00ae in patients with multiple sclerosis. Patient Prefer Adherence. 2017;11:415\u201321.","journal-title":"Patient Prefer Adherence"},{"key":"645_CR25","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.2147\/PPA.S130985","volume":"11","author":"M Krol","year":"2017","unstructured":"Krol M, de Voer G, Osowski U. Patient adherence to subcutaneous IFN beta-1a injections using the RebiSmart\u00ae injection device: a retrospective real-world study among Dutch and German patients with multiple sclerosis. Patient Prefer Adherence. 2017;11:1189\u201396.","journal-title":"Patient Prefer Adherence"},{"issue":"2","key":"645_CR26","first-page":"201","volume":"33","author":"H Schulze-Koops","year":"2015","unstructured":"Schulze-Koops H, Giacomelli R, Samborski W, Rednic S, Herold M, Yao R, et al. Factors influencing the patient evaluation of injection experience with the SmartJect autoinjector in rheumatoid arthritis. Clin Exp Rheumatol. 2015;33(2):201\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"10","key":"645_CR27","doi-asserted-by":"publisher","first-page":"1619","DOI":"10.1016\/j.clinthera.2006.10.006","volume":"28","author":"A Kivitz","year":"2006","unstructured":"Kivitz A, Cohen S, Dowd JE, Edwards W, Thakker S, Wellborne FR, et al. Clinical assessment of pain, tolerability, and preference of an autoinjection pen versus a prefilled syringe for patient self-administration of the fully human, monoclonal antibody adalimumab: the TOUCH trial. Clin Ther. 2006;28(10):1619\u201329.","journal-title":"Clin Ther"},{"issue":"3","key":"645_CR28","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1016\/j.hcl.2008.03.005","volume":"24","author":"AT Chacko","year":"2008","unstructured":"Chacko AT, Rozental TD. The rheumatoid thumb. Hand Clin. 2008;24(3):307\u201314.","journal-title":"Hand Clin"},{"issue":"1","key":"645_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/acr.22783","volume":"68","author":"JA Singh","year":"2016","unstructured":"Singh JA, Saag KG, Bridges SL Jr, Akl EA, Bannuru RR, Sullivan MC, et al. 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis. Arthritis Care Res. 2016;68(1):1\u201325.","journal-title":"Arthritis Care Res"},{"issue":"1","key":"645_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1136\/annrheumdis-2015-207524","volume":"75","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Breedveld FC, Burmester GR, Bykerk V, Dougados M, Emery P, et al. Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force. Ann Rheum Dis. 2016;75(1):3\u201315.","journal-title":"Ann Rheum Dis"}],"container-title":["Advances in Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-017-0645-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12325-017-0645-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12325-017-0645-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,10]],"date-time":"2022-08-10T02:20:10Z","timestamp":1660098010000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12325-017-0645-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,8]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["645"],"URL":"https:\/\/doi.org\/10.1007\/s12325-017-0645-1","relation":{},"ISSN":["0741-238X","1865-8652"],"issn-type":[{"value":"0741-238X","type":"print"},{"value":"1865-8652","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,8]]},"assertion":[{"value":"29 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2017","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}